Pharmax Global Private Limited
About Pharmax Global Private Limited
Data last updated:
Pharmax Global Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 November 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U47721MH2023PTC414512.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Ashish Kumar Jajodia and Ketan Dinesh Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹29.15 Lakh. For the same year it recorded a net loss of ₹27.22 Lakh (net margin -93.4%) and EBITDA of -₹27.22 Lakh (EBITDA margin -93.4%).
The company has 1 deal on record (1 rights issue); the latest was in March 2024. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Kyusep Healthcare Private Limited with revenue of ₹29.41 Lakh.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address405 Town Centre II, Andheri Kurla Road, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Pharmax Global Private Limited FY 2024 filings available
Pharmax Global Private Limited reported revenue of ₹29.15 Lakh for FY 2025.
Financial Statement Summary of Pharmax Global Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹27.22 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹27.22 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Pharmax Global Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -93.4% | •••• |
| Net Profit Margin | -93.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pharmax Global are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pharmax Global Private Limited
Pharmax Global Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kyusep Healthcare Private Limited | ₹29.41 Lakh (FY 2024) | •••• | •••• | 27.0% | •••• | Mumbai, Maharashtra, India |
| Flash Ventures Private Limited | ₹29.39 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Spectra Lifesciences Private Limited | ₹29.35 Lakh (FY 2017) | •••• | •••• | 21.0% | •••• | Thane, Maharashtra, India |
| Lifeforever Chemist Private Limited | ₹29.24 Lakh (FY 2022) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Litsa Pharmaceuticals Private Limited | ₹29.17 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Varanasi, Uttar Pradesh, India |
| Pharmax Global Private Limited this company | ₹29.15 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Trombone Pharma Private Limited | ₹29.13 Lakh (FY 2025) | •••• | •••• | 131.0% | •••• | Bangalore, Karnataka, India |
| Amugen Healthcare Private Limited | ₹29.09 Lakh (FY 2024) | •••• | •••• | 31.0% | •••• | Pune, Maharashtra, India |
| Aayushmaan Generics Private Limited | ₹29.08 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Hyderabad, Telangana, India |
| Wellset Pharma Private Limited | ₹29.07 Lakh (FY 2024) | •••• | •••• | 33.0% | •••• | Faridabad, Haryana, India |
| Redoux Chemist Private Limited | ₹29.05 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Pharmax Global by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Pharmax Global Private Limited
Pharmax Global has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Kumar Jajodia Also directs: Anaha Lifecare LLP, Anzen Exports Private Limited, Shubham Pharma Care Private Limited and 3 more | Director | 28 Nov 2023 | 2 Years 10 Months | Current |
| Ketan Dinesh Shah | Director | 24 Jun 2024 | 2 Years 3 Months | Current |
| Sarvesh Bishan Bansal Also directs: Pharmax India Private Limited, Pharmax Renewable Private Limited | Director | 28 Nov 2023 | 2 Years 10 Months | Current |
| Suyash Bansal Also directs: Pharmax India Private Limited | Director | 24 Jun 2024 | 2 Years 3 Months | Current |
Charges & Borrowings of Pharmax Global Private Limited
Pharmax Global Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Pharmax Global Private Limited
Pharmax Global Private Limited has 1 deal on record (1 rights issue); the latest was in March 2024.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Rights issue | ₹20 Lakh | Investors: Pharmax India Private Limited , Smick Laboratories Private Limited |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Pharmax Global Private Limited
Employment history and EPFO contributions of people linked to Pharmax Global.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharmax Global Private Limited
Pharmax Global Private Limited has 6 board changes on record since 2023: 4 appointments and 2 cessations. The latest: Ketan Dinesh Shah ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Pharmax Global Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharmax Global Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharmax Global Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharmax Global Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharmax Global Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmax Global Private Limited
Pharmax Global is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 November 2023 (3+ years old) and is registered under CIN U47721MH2023PTC414512.
Pharmax Global reported revenue of ₹29.15 Lakh for FY 2025.
Pharmax Global has 4 current directors:
- Ashish Kumar Jajodia - Director
- Ketan Dinesh Shah - Director
- Sarvesh Bishan Bansal - Director
- Suyash Bansal - Director
Pharmax Global reported a net loss of ₹27.22 Lakh (net margin -93.4%) and EBITDA of -₹27.22 Lakh (EBITDA margin -93.4%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Pharmax Global is U47721MH2023PTC414512. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmax Global was incorporated on 28 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Pharmax Global has 1 deal on record (1 rights issue); the latest was in March 2024.
The peers of Pharmax Global by revenue are Kyusep Healthcare Private Limited, Flash Ventures Private Limited, Spectra Lifesciences Private Limited, Lifeforever Chemist Private Limited, Litsa Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Ketan Dinesh Shah ceased to be Additional Director on 29 Sep 2024. Suyash Bansal ceased to be Additional Director on 29 Sep 2024. Ketan Dinesh Shah was appointed as Director on 24 Jun 2024. Pharmax Global has 6 board changes on record in total.
The registered office of Pharmax Global is at 405 Town Centre II, Andheri Kurla Road, Mumbai, Maharashtra, India – 400059.
Pharmax Global has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹25 Lakh.